Year-end Sale % OFF 
Abstract
In malignant lymphomas, cell kinetics has shown to be related with histologic type as well as with the clinical behaviour. The aim of our study was to investigate the relevance of cell proliferation parameters on overall survival in non‐Hodgkin's lymphomas as well as their relationship with prognostic factors such as International Prognostic Index (IPI). We performed DNA‐flow‐cytometry (S‐phase fraction and detection of DNA‐aneuploidy) as well as cytologic examination and the AgNOR technique in material obtained by fine needle aspiration of lymph nodes at diagnosis. The majority of the patients were stage IV by Ann Arbor and intermediate risk by IPI (42/55). When analyzing all patients together, histologic type by the WHO classification, IPI and the presence of a DNA‐aneuploid clone could not separate well patients with a different survival. For all patients, univariate Cox analysis revealed S‐phase (SPF) and AgNOR parameters to be of prognostic value. In the multivariate analysis, however, only SPF remained in the final model. Yet, when stratifying for DNA‐ploidy, only the total number of AgNORs/nucleus was an independent parameter. Looking only at the DNA‐diploid cases, the AgNOR pattern remained the most important parameter, whereas for the DNA‐aneuploid cases this was true for SPF. When studying patients with B large cell lymphoma separately, only DNA‐ploidy was a prognostic factor. In summary, cell kinetic parameters reveal important prognostic information in NHL patients. Furthermore, DNA‐aneuploidy seems to interfere with the analysis of the AgNOR pattern.
Highlights
Non-Hodgkin’s lymphomas (NHL) are a heterogeneous group of neoplastic disorders derived from the lymphoid system
Several studies have demonstrated the prognostic impact of the proliferation rate within each type of NHL, measured by different markers such as Ki-67, S-phase fraction determined by flow cytometry, or AgNOR analysis [5, 12,15,16,25,33]
We examined the influence of clinical features, stage as well as proliferation markers on survival in patients with NHLs
Summary
Non-Hodgkin’s lymphomas (NHL) are a heterogeneous group of neoplastic disorders derived from the lymphoid system. Cell kinetics of NHLs has been extensively studied, providing a better understanding of the molecular abnormalities leading to alterations in cell proliferation and apoptosis observed in the different types [28,34]. In NHLs with a small growth fraction, cell accumulation is due to a prolonged cell survival with inhibition of apoptosis [15,24,28]. Several studies have demonstrated the prognostic impact of the proliferation rate within each type of NHL, measured by different markers such as Ki-67, S-phase fraction determined by flow cytometry, or AgNOR analysis [5, 12,15,16,25,33]
Sign-in/Register to view highlights & summary 
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
